|Issue Date||04 Aug 2021 - 06 Aug 2021|
|Issue Size||₹401.54 Cr|
|Market Lot||30 Shares|
|Shares on Offer||5,142,067|
|Subject to Sauda||N/A|
|Listing Date||17 Aug 2021|
Founded in the year 2001, Windlas Biotech provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world
They employ 954 employees at their four state-of-the-art manufacturing facilities in Dehradun, Uttarakhand India. They also have a salesforce and distribution network spread across 14 states. They market their own manufactured authentic nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities at affordable prices. “The registered name of the company is Windlas Biotech Limited (Formerly known as Windlas Biotech Private Limited).
Ashok Kumar Windlass, Hitesh Windlass, Manoj Kumar Windlass, and AKW WBL Family Pvt Trust are the company promoters.
|Total Assets (In ₹ Millions)||3,384.88||2,981.80||2,898.87|
|Total Revenue (In ₹ Millions)||3,313.39||3,115.25||3,565.76|
|Profit After Tax (PAT) (In ₹ Millions)||162.13||638.22||111.98|
|Date||GMP||Kostak||Subject to Sauda|
|07 Aug 2021||₹110-120||N/A||N/A|
|03 Aug 2021||₹125-130||N/A||N/A|
|31 Jul 2021||₹150-155||N/A||N/A|
|Date & Time||QIB||NII||RII||Total|
|Day 1 - 04 Aug 2021||0.00||0.34||6.15||3.17|
|Day 2 - 05 Aug 2021||0.04||1.12||13.52||7.06|
|Day 3 - 06 Aug 2021||24.40||15.73||24.22||22.44|
Please click the link below to check the IPO allotment status.IPO Allotment Status
Windlas Biotech Limited IPO will open on 04 Aug 2021 and close on 06 Aug 2021.
Windlas Biotech Limited IPO will list on 17 Aug 2021.
The offer price of Windlas Biotech Limited IPO is ₹448-460.
The lot size of Windlas Biotech Limited IPO is 30.
The Grey Market Premium (GMP) price of Windlas Biotech Limited IPO is ₹110-120.
The Kostak price of Windlas Biotech Limited IPO is Not Available at the moment.
The Subject to Sauda price for Windlas Biotech Limited IPO is Not Available at the moment.
Please Leave Your Message